These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3141672

  • 1. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and diphosphonate EHDP. Protocol of study I, osteoporosis trial Hannover.
    Hesch RD, Heck J, Delling G, Keck E, Reeve J, Canzler H, Schober O, Harms H, Rittinghaus EF.
    Klin Wochenschr; 1988 Oct 03; 66(19):976-84. PubMed ID: 3141672
    [Abstract] [Full Text] [Related]

  • 2. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].
    Delling G, Dreyer T, Hahn M, Vogel M, Rittinghaus EF, Hesch RD.
    Z Orthop Ihre Grenzgeb; 1990 Oct 03; 128(1):1-5. PubMed ID: 2138378
    [Abstract] [Full Text] [Related]

  • 3. Morphological analysis of iliac crest bone biopsies in patients with osteoporosis and treatment according to the ADFR concept with (1-38)hPTH and diphosphonate (EHDP)--Osteoporosis Study I, Hannover.
    Delling G, Dreyer T, Vogel M, Hahn M, Rittinghaus EF, Hesch RD.
    Klin Wochenschr; 1989 May 15; 67(10):556. PubMed ID: 2500559
    [No Abstract] [Full Text] [Related]

  • 4. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
    Reeve J, Arlot M, Bernat M, Charhon S, Edouard C, Slovik D, Vismans FJ, Meunier PJ.
    Metab Bone Dis Relat Res; 1981 May 15; 3(1):23-30. PubMed ID: 7266363
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human parathyroid peptide treatment of vertebral osteoporosis.
    Reeve J, Arlot ME, Bradbeer JN, Hesp R, Mcally E, Meunier PJ, Zanelli JM.
    Osteoporos Int; 1993 May 15; 3 Suppl 1():199-203. PubMed ID: 8461559
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
    Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP.
    J Clin Endocrinol Metab; 2000 Sep 15; 85(9):3069-76. PubMed ID: 10999788
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F, Nieves J, Woelfert L, Formica C, Gordon S, Shen V, Lindsay R.
    J Bone Miner Res; 2001 May 15; 16(5):925-31. PubMed ID: 11341338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The turnover time of calcium in the exchangeable pools of bone in man and the long-term effect of a parathyroid hormone fragment.
    Reeve J.
    Clin Endocrinol (Oxf); 1978 Jun 15; 8(6):445-55. PubMed ID: 668151
    [Abstract] [Full Text] [Related]

  • 16. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetić K, Müller R, Bilezikian J, Lindsay R.
    J Bone Miner Res; 2001 Oct 15; 16(10):1846-53. PubMed ID: 11585349
    [Abstract] [Full Text] [Related]

  • 17. Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest.
    Lockwood DR, Vogel JM, Schneider VS, Hulley SB.
    J Clin Endocrinol Metab; 1975 Sep 15; 41(3):533-41. PubMed ID: 169289
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM.
    J Clin Invest; 1993 Mar 15; 91(3):1138-48. PubMed ID: 8450043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.